Skip to main content
Premium Trial:

Request an Annual Quote

Spotfire, Insightful Ink Technology Partnership

NEW YORK, Aug. 24 (GenomeWeb News) - Spotfire and Insightful said today that they have signed an agreement to offer integrated analytics software combining Spotfire's DecisionSite visual analytics with Insightful's advanced S-Plus numerical analytics.


According to Spotfire and Insightful, initial applications of the combined technologies are targeted at the companies' large common installed based within the life sciences market. The initial focus of the DecisionSite/S-Plus integration includes applications in drug discovery, pre-clinical, clinical, and post-marketing data analysis and visualization, they added.


Specific terms of the arrangement were not disclosed.


The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.